O. Usmani (London, United Kingdom), H. Chrystyn (Huddersfield, United Kingdom)
Inhaled corticosteroid fine particle dose from valved holding chambers
B. Rottier, T. de Vries, P. Hagedoorn, D. Gjaltema, M. van den Noort, E. Duiverman, H. Frijlink, A. de Boer (Groningen, Netherlands)
|   |
Pulsating aerosols offer new perspectives for the treatment of upper airway diseases – A study in healthy volunteers
W. Möller, U. Schuschnig, G. Khadem Saba, A. Krüner, K. Häussiner, M. Keller (Neuherberg, Gräfelfing, Gauting, Germany)
| |
Pharmacokinetic and pharmacodynamic characteristics of HFA and CFC pMDI formulations of budesonide
K. Clearie, P. Williamson, K. Meldrum, M. Gillen, L. G. Carlsson, M. Carlholm, J. Ekelund, B. Lipworth (Dundee, United Kingdom; Wilmington, United States Of America; Lund, Sweden)
| |
Comparison of the Aerochamber Plus spacer to the Aerochamber Plus with Flow-Vu spacer in children with asthma aged <5 years
W. Ammari, P. Chetcuti, T. Lee, H. Chrystyn (Bradford, , Huddersfield, United Kingdom)
| |
Effective and efficient nebulization of alpha1-proteinase inhibitor (alpha1-PI) for inhalation therapy using the AKITA2® APIXNEBÔ nebulizer system
N. Blazei, J. Gleske, B. Muellinger (Clayton, United States Of America; Gauting, Germany)
| |
In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
J. Mitchell, M. Nagel, V. Avvakoumova, H. MacKay, C. Doyle, J. Malpass (London, Canada)
| |
Manipulation of upper airway volume using a stepped mouthpiece
K. Nikander, I. Petherbridge, E. Scarberry, D. Von Hollen, J. Viviano, H. Chrystyn (Parsippany, Murrysville, United States Of America; Chichester, Huddersfield, United Kingdom; Mississauga, Canada)
| |
Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system]
Z. Podolec, J. Siekaniec (Cracow, Poland)
| |
Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB
Z. Podolec, J. Siekaniec (Cracow, Poland)
| |
Urinary pharmacokinetic method to identify the relative bioavailability of beclometasone dipropionate (BDP) to the lung and body following inhalation
A. Ahmed, L. Harding, H. Chrystyn (Huddersfield, United Kingdom)
| |
Assessment of long-term effects of combined extra-fine beclomethasone and formoterol treatment in asthma patients using functional imaging
W. Vos, L. De Backer, C. Van Holsbeke, S. Vinchurkar, A. Devolder, J. De Backer, W. De Backer (Antwerp, Edegem, Ghent, Belgium)
| |
In-vitro comparison of tobramycin nebulised using two different nebuliser systems
R. Faulkner, L. Harding, H. Chrystyn (Huddersfield, United Kingdom)
| |
Comparison of efficacy and safety of Obucort Swinghaler with Pulmicot Turbuhaler in mild to moderate severe asthma patients
Y. L. Chou, W. T. Liu, H. C. Lin, H. P. Kuo, C. H. Wang (TaoYuan, Taiwan)
| |
A comparative study on systemic pharmacodynamic effects of two HFA formulations of salmeterol xinafoate, in healthy subjects
S. Chandran, N. Morde, J. Rebello, S. Chachad, S. Purandare, G. Malhotra, A. Lulla (Mumbai, India)
| |
A randomised, 4-way crossover study to examine the lung pharmacodynamic effects of single inhaled doses of tiotropium (18 μg), salmeterol (50 μg), tiotropium (18 μg) and salmeterol (50 μg) and placebo using whole body plethysmography in healthy subjects
D. Serdarevic, R. Fuhr, N. Clarke, J. Hamlin (Sandwich, United Kingdom; Berlin, Germany)
| |
Do ICS/LABA fixed combinations provide superior asthma control compared to separate inhalers?
P. J. Barnes, G. Nicolini, A. Bizzi, D. Singh (London, Manchester, United Kingdom; Parma, Italy)
| |
Delivered dose and fine particle dose of aclidinium bromide 200 µg via the Genuair® inhaler are independent of flow rate within the working range of the device
K. Block, S. Folger, B. Fyrnys, S. Kurtz (Bad Homburg, Germany)
| |